Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Clinical trial NCT00263601 · COMPLETED

Trial details

NCT number: NCT00263601
Sponsor: Allergopharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Grass Pollen Allergy

Start date: 2001-11-01
Primary completion: 2004-05-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.